
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>The San Diego Consensus for Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease</title>
<style>

<style>
/* ===== GENERAL LAYOUT ===== */
body {
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    background: linear-gradient(135deg, #eef2ff, #fafafa);
    color: #2c2c2c;
    padding: 30px;
    margin: 0;
}

/* Centered mindmap container */
.mindmap {
    max-width: 800px;
    margin: auto;
    font-size: 20px;
    line-height: 1.7;
}

/* ===== LISTS ===== */
.mindmap ul {
    margin: 0.6em 0 1em 1.5em;
    padding-left: 1.4em;
    list-style: disc;
    color: #555;
    font-size: 0.95em;
    font-weight: 400;
    line-height: 1.6;
}

.mindmap li::marker {
    color: #8b5cf6; /* accent bullet color */
}

.mindmap li {
    margin-bottom: 6px;
    padding-left: 4px;
}

/* ===== COLLAPSIBLE SECTIONS ===== */
.mindmap details {
    /* FIX: Increased border width and used a darker color */
    border-left: 5px solid #7c3aed; 
    background: #ffffff;
    margin: 8px 0;
    /* FIX: Corrected typo "20x" to "20px" */
    padding: 9px 25px; 
    border-radius: 20px;
    box-shadow: 0 4px 12px rgba(139, 92, 246, 0.1);
    transition: all 0.3s ease;
    position: relative;
}

/* Subsection (nested details) */
.mindmap details > div > details {
    margin-left: -8px;
    /* FIX: Used a darker, more saturated color for the nested border */
    border-color: #9333ea; 
    background: #faf7ff;
}

/* Subtle hover feedback */
.mindmap details:hover {
    box-shadow: 0 6px 18px rgba(139, 92, 246, 0.18);
    background: linear-gradient(135deg, #ffffff, #f5f0ff);
}

/* ===== SUMMARY HEADERS ===== */
.mindmap summary {
    cursor: pointer;
    font-size: 1.1em;
    font-weight: 600;
    list-style: none;
    position: relative;
    /* FIX: Increased padding slightly to prevent text from touching the arrow icon */
    padding-left: 24px; 
    color: #4c1d95;
    outline: none;
}

/* Custom arrow icon */
.mindmap summary::before {
    content: "▶";
    position: absolute;
    left: 0;
    top: 2px;
    transition: transform 0.3s ease;
    font-size: 1em;
    color: #7c3aed;
}

/* Rotated arrow when open */
.mindmap details[open] > summary::before {
    transform: rotate(90deg);
}

/* Section title emphasis */
.mindmap summary strong {
    display: block;
    font-size: 1.25em;
    color: #4c1d95;
}

.mindmap summary em {
    font-style: normal;
    color: #6b21a8;
    font-size: 0.95em;
}

/* Open section highlighting */
.mindmap details[open] > summary {
    background: #f3e8ff;
    border-radius: 8px;
    padding: 6px 10px;
}

/* Smooth fade for expanded content */
.mindmap details[open] > div {
    animation: fadeIn 0.3s ease-in;
}

/* ===== DESCRIPTION BOXES ===== */
.mindmap .desc-box {
    background: #fdfcff;
    border: 2px solid #e5d9fb;
    border-left: 4px solid #c084fc;
    padding: 6px 10px;
    margin: 12px 0 18px 0;
    border-radius: 12px;
    box-shadow: 0 1px 3px rgba(160, 104, 255, 0.05);
    transition: background 0.3s ease;
}
.mindmap .desc-box:hover {
    background: #f8f4ff;
}

/* ===== ANIMATIONS ===== */
@keyframes fadeIn {
    from { opacity: 0; transform: translateY(-3px); }
    to { opacity: 1; transform: translateY(0); }
}

/* ===== BUTTONS ===== */
button {
    background-color: #7c3aed;
    color: white;
    border: none;
    padding: 10px 16px;
    margin: 0 6px;
    font-size: 2em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s ease;
}
button:hover {
    background-color: #6b21a8;
    transform: scale(1.05);
}

/* ===== FLOATING CONTROL PANEL ===== */
#level-controls {
    position: fixed;
    bottom: 30px;
    left: 85%;
    transform: translateX(-50%);
    background: rgba(255, 255, 255, 0.05);
    padding: 10px 16px;
    border-radius: 12px;
    box-shadow: 0 4px 12px rgba(0, 0, 0, 0.15);
    z-index: 9999;
    backdrop-filter: blur(6px);
    cursor: move;
    display: flex;
    align-items: center;
    gap: 6px;
}

/* Buttons inside the panel */
#level-controls button {
    background-color: rgba(124, 58, 237, 0.85);
    color: white;
    border: none;
    padding: 8px 14px;
    font-size: 2em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s ease;
}
#level-controls button:hover {
    background-color: rgba(107, 33, 168, 0.95);
    transform: scale(1.05);
}

/* Search input inside panel */
#level-controls input {
    border: 1px solid #d5c4ff;
    border-radius: 8px;
    padding: 7px 10px;
    font-size: 0.95em;
    outline: none;
    width: 150px;
    transition: border-color 0.2s ease;
}
#level-controls input:focus {
    border-color: #8b5cf6;
}

/* Search count text */
#searchCount {
    margin-left: 8px;
    font-style: italic;
    color: #4c1d95;
    font-size: 0.9em;
}

/* ===== SEARCH HIGHLIGHT ===== */
mark.search-highlight {
    background-color: #fff59d;
    color: #000;
    border-radius: 3px;
    padding: 1px 3px;
}



/* ===== CLICK-TO-REVEAL: Spoiler Blur Style ===== */
.mindmap q {
    cursor: pointer;
    color: transparent;
    /* Apply a text-shadow with the same color as the text to create the blur effect */
    text-shadow: 0 0 8px #2c2c2c; 
    user-select: none;
    transition: text-shadow 0.3s ease;
}

.mindmap q:hover {
    text-shadow: 0 0 4px #2c2c2c; /* Reduce blur on hover */
}

/* Style for the revealed text */
.mindmap q.is-revealed {
    color: inherit;
    text-shadow: none;
    cursor: default;
    user-select: text;
}




/*for full control button*/
/* ===== CLICK-TO-REVEAL: Spoiler Blur Style (with Read Mode) ===== */

/* This rule applies the blur ONLY when the mindmap is NOT in read-mode. */
.mindmap:not(.read-mode) q {
    cursor: pointer;
    color: transparent;
    text-shadow: 0 0 8px #2c2c2c; 
    user-select: none;
    transition: text-shadow 0.3s ease, color 0.3s ease;
}

.mindmap:not(.read-mode) q:hover {
    text-shadow: 0 0 4px #2c2c2c; /* Reduce blur on hover */
}

/* This combined rule handles BOTH cases for revealing text:
   1. The entire mindmap is in read-mode.
   2. An individual <q> has been clicked (in quiz mode).
*/
.mindmap.read-mode q,
.mindmap q.is-revealed {
    color: inherit;
    text-shadow: none;
    cursor: default;
    user-select: text;
}


</style>

</style>
</head>
<body>

<!-- Updated Controls -->
<div id="level-controls" onmousedown="dragElement(this)">
    <button onclick="zoomIn()">+</button>
    <button onclick="zoomOut()">-</button>
    <button onclick="resetView()">=</button>
    <!-- NEW: READ MODE TOGGLE BUTTON -->
    <button onclick="toggleReadMode()">Q/R</button>
</div>

<div class="mindmap">

    <div class="mindmap">
        
        <details>
            <summary><strong>The San Diego Consensus for Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease</strong></summary>
            <div>
                <ul><li>- Am J Gastroenterol 2025;00:1–15.</li><li>- https://doi.org/10.14309/ajg.0000000000003482</li></ul>
                
        <details>
            <summary><strong>Knowledge Test</strong></summary>
            <div>
                <ul><li>- What is the recommended duration for a trial of twice-daily PPI therapy for LPS to determine a symptomatic response?</li><li>- What percentage of patients diagnosed with LPR have normal objective ambulatory reflux monitoring studies?</li><li>- What distal esophageal acid exposure time (AET) on ambulatory reflux monitoring is considered definitively abnormal and meets the criteria for proven GERD?</li><li>- What validated patient-reported outcome instrument can help identify individuals with elevated levels of hypervigilance and anxiety related to their LPS?</li><li>- What is the diagnostic yield of GERD in patients referred for LPS when using prolonged wireless pH monitoring versus 24-hour pH impedance monitoring?</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Core Concepts: Definition & Terminology</strong></summary>
            <div>
                <ul><li>- A key distinction is made between <b>Laryngopharyngeal Symptoms (LPS)</b> and the objective diagnosis of <b>Laryngopharyngeal Reflux Disease (LPRD)</b>.</li><li>- The presence of LPS does <u>NOT</u> equate to LPRD.</li></ul>
                
        <details>
            <summary><strong><b>Laryngopharyngeal Symptoms (LPS)</b></strong></summary>
            <div>
                <ul><li>- Chronic and frequent throat/upper airway symptoms with the <u>potential</u> to be induced by reflux.</li><li>- The term <b>LPS</b> itself does <u>not</u> implicate reflux as the etiology.</li></ul>
                
        <details>
            <summary><strong>Criteria</strong></summary>
            <div>
                <ul><li>- <b>Frequent:</b> Occurring at least <q>twice weekly</q>.</li><li>- <b>Chronic:</b> Present for more than <q>8 weeks</q>.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Included Symptoms</strong></summary>
            <div>
                <ul><li>- <b>Cough</b> (<q>89%</q> agreement)</li><li>- <b>Voice hoarseness/change</b> (<q>80%</q> agreement)</li><li>- <b>Throat clearing</b> (<q>86%</q> agreement)</li><li>- <b>Excess throat phlegm</b> (<q>82%</q> agreement)</li><li>- <b>Throat pain/sore throat</b> (<q>89%</q> agreement)</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Globus</strong></summary>
            <div>
                <ul><li>- An important symptom warranting evaluation.</li><li>- Often a <u>negative predictor</u> of reflux physiology.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Symptom Presentation</strong></summary>
            <div>
                <ul><li>- Can be <b>isolated</b>.</li><li>- Can be <b>concurrent</b> with typical esophageal reflux symptoms (heartburn, regurgitation, chest pain).</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong><b>Laryngopharyngeal Reflux Disease (LPRD)</b></strong></summary>
            <div>
                <ul><li>- True LPRD is much less common than LPS.</li><li>- As many as <q>60%</q> of patients diagnosed with LPR have normal objective ambulatory reflux monitoring studies.</li><li>- The proportion of individuals with LPS found to have objective LPRD is only <q>~35%</q>.</li></ul>
                
        <details>
            <summary><strong>Diagnostic Requirements</strong></summary>
            <div>
                <ul><li>- Requires BOTH:</li><li>- 1. Chronic, troublesome <b>LPS</b>.</li><li>- 2. <b>Objective evidence</b> supporting a relationship between symptoms and gastroesophageal reflux.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Forms of Objective Evidence</strong></summary>
            <div>
                <ul><li>- LPS response to anti-reflux therapy (<u>only if</u> esophageal symptoms coexist).</li><li>- OR Diagnostic evidence on upper GI endoscopy or ambulatory reflux monitoring.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Impact & Burden</strong></summary>
            <div>
                <ul><li>- Accounts for up to <q>10%</q> of otolaryngology and gastroenterology visits.</li><li>- Healthcare costs are <q>5.4 times higher</q> than for GERD, partly from diagnostic uncertainty.</li><li>- Significant negative impact on quality of life (anxiety, depression).</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Diagnostic Evaluation of LPS</strong></summary>
            <div>
                <ul><li>- A structured approach is needed, starting with laryngoscopy and symptom characterization based on the presence or absence of esophageal symptoms.</li></ul>
                
        <details>
            <summary><strong>Role of Laryngoscopy</strong></summary>
            <div>
                <ul><li>- <b>Primary Role:</b> A <u>necessary</u> step to assess for non-reflux causes, especially <b>malignancy</b>.</li><li>- <b>LPRD cannot be diagnosed based on laryngoscopy findings alone.</b></li></ul>
                
        <details>
            <summary><strong>Findings</strong></summary>
            <div>
                <ul><li>- Findings like infraglottic edema, mucosal hypertrophy, and erythema are <u>nonspecific</u> for LPRD.</li><li>- These findings may be present in healthy, asymptomatic individuals.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Scoring Instruments</strong></summary>
            <div>
                <ul><li>- Instruments like the <b>Reflux Finding Score (RFS)</b> and <b>Reflux Sign Assessment</b> are <u>not diagnostic</u> of LPRD due to suboptimal specificity.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Videostroboscopy</strong></summary>
            <div>
                <ul><li>- Should be performed when white-light laryngoscopy is unrevealing in patients with <b>hoarseness</b> to evaluate for other etiologies.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Symptom Characterization & Medical Trials</strong></summary>
            <div>
                <ul><li>- The first step is to determine if LPS is <b>isolated</b> or occurs with <b>concurrent esophageal reflux symptoms</b>.</li></ul>
                
        <details>
            <summary><strong>LPS <u>with</u> Esophageal Symptoms</strong></summary>
            <div>
                <ul><li>- A trial of medical anti-reflux management is <u>appropriate</u>.</li><li>- Should be accompanied by dietary and lifestyle modifications.</li></ul>
                
        <details>
            <summary><strong>PPI Trial</strong></summary>
            <div>
                <ul><li>- <b>Twice daily (BID) PPI</b> (e.g., omeprazole <q>20mg</q> BID).</li><li>- A <q><b>3-month</b></q> trial is sufficient to determine symptomatic response.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Alginate Therapy</strong></summary>
            <div>
                <ul><li>- Can be used in conjunction with a PPI trial.</li><li>- Taken <q>4 times daily</q> (after meals and before bedtime).</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong><u>Isolated</u> LPS</strong></summary>
            <div>
                <ul><li>- Empiric medical trials are <u>not recommended</u> as a first-line therapy.</li><li>- Reflux testing can personalize management better than empiric trials.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Esophageal Evaluation</strong></summary>
            <div>
                <ul><li>- Performed for LPS unresponsive to empiric trials (if applicable) or for isolated LPS.</li><li>- Includes Upper GI Endoscopy and/or Ambulatory Reflux Monitoring.</li></ul>
                
        <details>
            <summary><strong>Upper GI Endoscopy</strong></summary>
            <div>
                <ul><li>- Performed off acid suppression to establish GERD presence.</li><li>- Up to <q>47%</q> of patients with LPS may show erosive findings or hiatal hernia.</li></ul>
                
        <details>
            <summary><strong>Conclusive GERD Evidence</strong></summary>
            <div>
                <ul><li>- <b>Los Angeles (LA) grades <q>B, C, or D</q> esophagitis</b>.</li><li>- Biopsy-proven <b>Barrett’s esophagus</b>.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Supportive Evidence</strong></summary>
            <div>
                <ul><li>- Disrupted esophagogastric junction (e.g., hiatal hernia).</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Cervical Inlet Patch</strong></summary>
            <div>
                <ul><li>- Area of heterotopic gastric mucosa in the proximal esophagus.</li><li>- Association with LPS is unclear; value of ablation is not established.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Ambulatory Reflux Monitoring</strong></summary>
            <div>
                <ul><li>- The <u><b>reference standard</b></u> for diagnosing LPRD.</li><li>- Should be performed <b>off acid suppression</b> in patients with unproven GERD.</li></ul>
                
        <details>
            <summary><strong>Indications</strong></summary>
            <div>
                <ul><li>- <b>Required</b> prior to any invasive anti-reflux management (endoscopic or surgical).</li><li>- For isolated LPS to personalize management.</li><li>- Should be considered if long-term medical management is planned.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Modalities: pH-Impedance vs. Wireless pH</strong></summary>
            <div>
                <ul><li>- These two methods are <u>not mutually exclusive</u> and have distinct roles. (See Table 3)</li></ul>
                
        <details>
            <summary><strong>24-hour pH-Impedance</strong></summary>
            <div>
                <ul><li>- <b>Best for:</b> Patients with <u>isolated LPS</u> to understand mechanisms.</li><li>- Detects proximal, weakly-acidic, and non-acidic reflux events.</li><li>- HEMII-pH catheters can identify pharyngeal reflux in <q>81%</q> of patients.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>96-hour Wireless pH</strong></summary>
            <div>
                <ul><li>- <b>Best for:</b> Patients with <u>concomitant esophageal symptoms</u> and before escalating management.</li><li>- Accounts for day-to-day variability, which is a major advantage.</li><li>- Higher diagnostic yield for GERD in LPS patients (<q>50%</q>) compared to 24-hr pH-impedance (<q>27%</q>).</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Interpretation of Findings</strong></summary>
            <div>
                <ul><li>- Focuses on distal esophageal Acid Exposure Time (AET).</li></ul>
                
        <details>
            <summary><strong>Proven GERD</strong></summary>
            <div>
                <ul><li>- Distal esophageal AET <q><b>> 6.0%</b></q>.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Physiologic Reflux</strong></summary>
            <div>
                <ul><li>- Distal esophageal AET <q><b>< 4.0%</b></q>.</li><li>- If AET is <4.0% on <u>all 4 days</u> of wireless monitoring, it predicts a <b>low likelihood</b> of response to antisecretory therapy.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Oropharyngeal pH Monitoring (e.g., Restech)</strong></summary>
            <div>
                <ul><li>- <u>Not recommended</u> as a stand-alone tool.</li><li>- Has <b>poor specificity</b> for LPRD and poor concordance with other methods.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Laryngeal Hyperresponse & Hypervigilance</strong></summary>
            <div>
                <ul><li>- Addresses non-reflux mechanisms and <b>brain-larynx interactions</b> that contribute to LPS.</li><li>- These factors can be the primary etiology of LPS, with or without pathologic reflux.</li></ul>
                
        <details>
            <summary><strong>Behavioral Factors</strong></summary>
            <div>
                <ul><li>- A predisposition to manifest emotional distress through sensory changes in the larynx or voice.</li></ul>
                
        <details>
            <summary><strong>Laryngeal Hyperresponse</strong></summary>
            <div>
                <ul><li>- Repetitive laryngeal behaviors ---> throat clearing, coughing, breath-holding.</li><li>- Biomechanical strain at the vocal folds ---> altered voice quality or globus sensation.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Laryngeal Hypervigilance</strong></summary>
            <div>
                <ul><li>- Increased threat-induced attention to the larynx.</li><li>- Often coexists with symptom-specific anxiety (fear/worry about LPS and its consequences).</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Laryngeal Cognitive-Affective Tool (LCAT)</strong></summary>
            <div>
                <ul><li>- A validated patient-reported outcome (PRO) instrument.</li><li>- Helps identify individuals with elevated levels of <b>hypervigilance</b> and symptom-specific <b>anxiety</b> related to their LPS.</li><li>- Useful for selecting candidates who may benefit from behavioral intervention.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Laryngeal Behavioral Therapy</strong></summary>
            <div>
                <ul><li>- Aims to modify dysregulated laryngeal patterns and cognitive perspectives associated with LPS.</li><li>- Can be used alone or in combination with other modalities like neuromodulators.</li></ul>
                
        <details>
            <summary><strong><b>Laryngeal Recalibration Therapy (LRT)</b></strong></summary>
            <div>
                <ul><li>- Provided by a <u>voice-specialized speech-language pathologist (SLP)</u>.</li><li>- A structured approach combining:</li><li>- - Traditional voice therapy techniques.</li><li>- - Autonomic regulation (heart rate variability biofeedback).</li><li>- - Cognitive reframing (Acceptance and Commitment Therapy).</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Cognitive Behavioral Therapy (CBT)</strong></summary>
            <div>
                <ul><li>- Considered if psychological processes persist after LRT or neuromodulation.</li><li>- Targets specific cognitive, emotional, and behavioral processes exacerbating symptoms.</li><li>- Delivered by a mental health professional with specialized health psychology training.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Pharmacologic Neuromodulation</strong></summary>
            <div>
                <ul><li>- May improve <b>laryngeal hypersensitivity</b>.</li><li>- Considered in LPRD with poor response to acid suppression or in isolated LPS with negative reflux testing.</li></ul>
                
        <details>
            <summary><strong>Gabapentin & Pregabalin</strong></summary>
            <div>
                <ul><li>- May be an effective adjunct to LRT for LPS, especially <b>cough</b>.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Tricyclic Antidepressants (TCAs)</strong></summary>
            <div>
                <ul><li>- May help LPS symptoms.</li><li>- <u>Caution:</u> Anticholinergic side effects like <b>xerostomia</b> (dry mouth) should be monitored.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>SSRIs & SNRIs</strong></summary>
            <div>
                <ul><li>- Not specifically studied in LPS.</li><li>- May benefit individuals with LPS and concomitant clinical <b>anxiety</b> and/or <b>depression</b>.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Patient-Reported Outcome (PRO) Instruments & Risk Tools</strong></summary>
            <div>
                <ul><li>- PROs are used to assess symptoms and treatment response, but are <u>not diagnostic tools</u> for LPRD.</li></ul>
                
        <details>
            <summary><strong>LPRD-Specific PROs</strong></summary>
            <div>
                <ul><li>- Instruments like LPR-HRQL, Reflux Symptom Index (RSI), and Reflux Symptom Score (RSS) are <u><b>not specific enough to diagnose LPRD</b></u>.</li></ul>
                
        <details>
            <summary><strong>Reflux Symptom Index (RSI)</strong></summary>
            <div>
                <ul><li>- Nonspecific for LPRD but can track laryngological complaints over time.</li><li>- A cutoff of <q>≥13</q> is <u>not</u> considered clinically significant or reliable for diagnosis.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>GERD-Specific PROs</strong></summary>
            <div>
                <ul><li>- Instruments like GERDQ and GERD-HRQL are useful for assessing <b>esophageal symptoms</b> but are not specific for LPS.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Risk Stratification Tools</strong></summary>
            <div>
                <ul><li>- Tools like HAS-BEER and COuGH RefluX are promising but require more data before they can be adopted into the consensus algorithm.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>San Diego Consensus: Clinical Paradigm Summary</strong></summary>
            <div>
                <ul><li>- This consensus provides a modern, evidence-based, interdisciplinary paradigm for LPS and LPRD.</li></ul>
                
        <details>
            <summary><strong>Core Principle: Distinguish LPS from LPRD</strong></summary>
            <div>
                <ul><li>- <b>LPS:</b> The symptomatic presentation (cough, throat clearing, etc.).</li><li>- <b>LPRD:</b> The objective diagnosis, requiring both LPS and objective evidence of reflux.</li><li>- This distinction is critical to separate patients needing reflux therapy from those needing symptomatic/behavioral interventions.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Underlying Mechanisms</strong></summary>
            <div>
                <ul><li>- Mechanisms are varied and not limited to simple reflux, explaining why fewer than <q>50%</q> of LPS patients respond to antisecretory therapy.</li><li>- Mechanisms include:</li><li>- - <b>Direct Injury:</b> From acid, pepsin, bile salts.</li><li>- - <b>Indirect Injury:</b> Repetitive trauma from vagally-mediated cough/clearing.</li><li>- - <b>Reflex Pathway:</b> Vagally-mediated airway stimulation.</li><li>- - <b>Brain-Larynx Interaction:</b> Heightened cognitive-behavioral responses.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Proposed Evaluation & Management Algorithm</strong></summary>
            <div>
                <ul><li>- See Figure 1 for the full algorithm.</li></ul>
                
        <details>
            <summary><strong>Initial Evaluation</strong></summary>
            <div>
                <ul><li>- <b>1. Laryngoscopy:</b> To rule out non-reflux causes (e.g., malignancy).</li><li>- <b>2. Symptom Assessment:</b> Differentiate between <u>isolated LPS</u> and LPS with <u>concurrent esophageal symptoms</u>.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Management Pathway: LPS + Esophageal Symptoms</strong></summary>
            <div>
                <ul><li>- <b>1. Empiric Trial:</b> Twice-daily PPI for <q>3 months</q> ± alginates, plus lifestyle changes.</li><li>- <b>2. Assess Response:</b></li><li>- - <u>Full Response:</u> Likely LPRD, continue management.</li><li>- - <u>Partial/No Response:</u> Proceed to objective esophageal testing.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Management Pathway: Isolated LPS</strong></summary>
            <div>
                <ul><li>- <b>1. Objective Testing First:</b> Proceed with objective esophageal testing (endoscopy, reflux monitoring) <u>before</u> anti-reflux management to personalize care.</li><li>- <b>2. Consider Brain-Larynx Interaction:</b> Disordered laryngeal behaviors should be considered at the outset.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Role of Objective Testing</strong></summary>
            <div>
                <ul><li>- <b>Required</b> before any invasive anti-reflux therapy (endoscopic or surgical).</li><li>- Absence of GERD (AET <q><4.0%</q>) makes it unlikely that anti-reflux therapies will improve LPS.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Consideration for Non-Responders</strong></summary>
            <div>
                <ul><li>- In isolated LPS or when LPS fails to respond to anti-reflux therapies (even in confirmed LPRD), consider overlap with <b>laryngeal hyperresponsiveness and hypervigilance</b>.</li><li>- Recommend behavioral therapy (LRT, CBT) and/or neuromodulation.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
    </div>
    
</div>

<br>
<br>
<br>
<br>
<br>


<script>
// --- State Management for Expansion Level ---
let currentLevel = 1; 
const maxLevel = 10;
const minLevel = 1;

// --- Core Function to Set Mindmap Expansion ---
function setMindmapLevel(level) {
    const allDetails = document.querySelectorAll('.mindmap details');
    allDetails.forEach(detail => detail.removeAttribute('open'));
    allDetails.forEach(detail => {
        let depth = 0;
        let parent = detail.parentElement;
        while (parent && parent.tagName !== 'BODY') {
            if (parent.tagName === 'DETAILS') {
                depth++;
            }
            parent = parent.parentElement;
        }
        if (depth < level) {
            detail.setAttribute('open', '');
        }
    });
}

// --- Control Functions ---
function zoomIn() {
    if (currentLevel < maxLevel) {
        currentLevel++;
        setMindmapLevel(currentLevel);
    }
}

function zoomOut() {
    if (currentLevel > minLevel) {
        currentLevel--;
        setMindmapLevel(currentLevel);
    }
}

function resetView() {
    currentLevel = minLevel;
    setMindmapLevel(currentLevel);
}


// --- NEW: Function to Toggle Read/Quiz Mode ---
function toggleReadMode() {
    const mindmapContainer = document.querySelector('.mindmap');
    if (mindmapContainer) {
        mindmapContainer.classList.toggle('read-mode');
    }
}

// --- Draggable Controls ---
function dragElement(elmnt) {
    let pos1 = 0, pos2 = 0, pos3 = 0, pos4 = 0;
    const onMouseDown = (e) => {
        e = e || window.event;
        e.preventDefault();
        pos3 = e.clientX;
        pos4 = e.clientY;
        document.onmouseup = closeDragElement;
        document.onmousemove = elementDrag;
    };
    const elementDrag = (e) => {
        e = e || window.event;
        e.preventDefault();
        pos1 = pos3 - e.clientX;
        pos2 = pos4 - e.clientY;
        pos3 = e.clientX;
        pos4 = e.clientY;
        elmnt.style.top = (elmnt.offsetTop - pos2) + "px";
        elmnt.style.left = (elmnt.offsetLeft - pos1) + "px";
        elmnt.style.transform = "none";
        elmnt.style.bottom = "auto";
    };
    const closeDragElement = () => {
        document.onmouseup = null;
        document.onmousemove = null;
    };
    if (document.getElementById(elmnt.id)) {
        document.getElementById(elmnt.id).onmousedown = onMouseDown;
    } else {
        elmnt.onmousedown = onMouseDown;
    }
}




// --- Initial Setup ---
window.addEventListener('DOMContentLoaded', () => {
    // Set the initial mindmap view
    setMindmapLevel(currentLevel);

    // Get the draggable controls element
    const controls = document.getElementById('level-controls');
    if (controls) {
        dragElement(controls);
    }

    // --- CORRECTED & IMPROVED: Setup for Click-to-Reveal ---
    const mindmapContainer = document.querySelector('.mindmap');
    if (mindmapContainer) {
        mindmapContainer.addEventListener('click', function(event) {
            // Use .closest() to find the nearest parent <q> tag.
            // This is more robust than checking event.target.tagName.
            const quoteElement = event.target.closest('q');
            
            if (quoteElement) {
                // Add the 'is-revealed' class to show the text
                quoteElement.classList.add('is-revealed');
            }
        });
    }
});
</script>

</body>
</html>
